Microvast Holdings Faces Securities Fraud Class Action as Stock Prices Plummet
On July 28, 2026, Glancy Prongay Wolke & Rotter LLP, a prominent national shareholder rights law firm, announced the filing of a securities fraud class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST), a manufacturer of electric vehicle battery systems. This move comes as a response to allegations regarding misleading statements that have significantly impacted the company’s stock value and investor confidence.
1. Background of the Allegations
The class action lawsuit represents investors who acquired Microvast common stock between April 1, 2025, and March 16, 2026. The pressing concern stems from a report published by Grizzly Research on June 25, 2025, which claimed that Microvast was exaggerating its business capabilities. The report specifically pointed to the company’s production facility in Huzhou, China, asserting that it was fabricating substantial parts of its business operations and overstating economic opportunities related to its commercial partnerships.
Key Events Leading to the Lawsuit
- CFO Departure: Just three months after joining the company, Microvast announced the departure of its Chief Financial Officer on August 1, 2025. This sudden leadership change raised eyebrows among investors, leading to a nearly 10% drop in stock price shortly thereafter, closing at $2.72 per share on August 4, 2025.
- Production Delays: On November 10, 2025, the company disclosed that the much-anticipated Huzhou Phase 3.2 expansion, which was expected to enhance production capacity, would not be operational until the first quarter of 2026. This news contradicted earlier assurances that production capacity would be ready by the fourth quarter of 2025, resulting in a 10% decline in stock price to $4.48 per share.
- Disappointing Financial Results: The situation worsened on March 16, 2026, when Microvast reported a drastic decline in gross margins to approximately 1%, down from 36% the previous year. The report attributed this decline to inventory impairment charges and underperformance in various markets, including regulatory challenges in South Korea. Following this announcement, the stock plummeted by 34.2%, closing at $1.52 per share on March 17, 2026.
2. The Nature of the Lawsuit
The class action lawsuit alleges that Microvast and its executives made materially false and misleading statements to investors while failing to disclose significant adverse facts regarding the company’s operations and prospects. Specifically, the lawsuit claims that:
- The company overstated its production capabilities and the status of the Huzhou Phase 3.2 expansion.
- Management misled investors about the company's ability to achieve margin targets due to inventory management issues.
- The optimistic outlook provided by the company lacked a reasonable basis, given the underlying operational difficulties.
3. Call to Action for Investors
Investors who purchased Microvast common stock during the class period have until September 21, 2026, to file a lead plaintiff motion in connection with the class action. Shareholders are encouraged to seek legal counsel to explore their options for potentially recovering losses under federal securities laws.
Conclusion
As Microvast Holdings faces serious allegations and the implications of a class action lawsuit, the financial community will be closely monitoring the developments surrounding this case. Investors are advised to stay informed about their rights and the evolving situation, as the outcome may have significant ramifications for both the company and its stakeholders.
